A new study published in the European Journal of Preventive Cardiology identified a strong link between vitamin D levels in the blood and cardiorespiratory fitness (CRF)—with individuals in the top quartile of vitamin D being almost three times more fit than those in the bottom quartile after adjustment for clinical characteristics.

Low blood pressure (BP) and weight loss could signal an impending diagnosis of dementia, while elevated blood glucose levels may represent a consistent risk factor for the condition, according to a 14-year study published in the October issue of JAMA Psychiatry.

Figures released by England’s National Health Service have revealed that around 500 U.K. residents die prematurely each week from complications of diabetes, including amputations, CVD, stroke and kidney disease.

The FDA has approved canagliflozin (Invokana) to reduce the risk of major adverse cardiovascular events (MACE) including stroke, heart attack and cardiac death in patients with type 2 diabetes and established cardiovascular disease. It is the first oral diabetes medication to gain this indication, according to drug manufacturer Janssen Pharmaceutical Companies.

Evolocumab appears to be equally effective at reducing LDL cholesterol and preventing cardiovascular events regardless of a patient’s kidney function, according to a new subanalysis of the FOURIER outcomes study presented at the American Society of Nephrology’s annual Kidney Week in San Diego.

Overweight and obese women might face better odds against diabetes, insulin resistance and CVD than men, according to a rodent study out of York University in Toronto.

Managing their high blood pressure is the best way patients with diabetes can avoid hypertensive emergencies, according to research published in Clinical and Experimental Hypertension this fall.

A free phone app helped a low-income, obese patient population achieve clinically meaningful weight loss, researchers from Duke University reported in the American Journal of Preventive Medicine.